Morbidity and mortality from Pseudomonas spp. infections, remains high despite the availability of antibiotics to which the microorganism is sensitive (2, 3, 16) . Moreover, exposure of Gram-negative organisms to antibacterial agents can also result in endotoxin release and determine septic shock (13, 14, 22) .
Antimicrobial peptides are recognized as an important component of the nonspecific host defence system against invading pathogens (1, 12, 13) . Typically, these peptides are relatively short, positively charged, amphiphilic and are reported to be active against bacteria, fungi, viruses and protozoa (11) (12) (13) 17) . They bind to the negatively charged residues of LPS of the outer membrane by electrostatic and hydrophobic interactions and so determining the key mechanistic step in the killing of gram-negative organisms (9, 10, 13) . Cathelicidins are characterized by conserved propeptide sequences and comprise a family of antimicrobial peptides that have been identified in epithelial tissues and some myeloid cells of humans and animals (23) .
Tritrpticin, a member of the cathelicidin family, is a 13-amino acid antimicrobial peptide. The primary structure of tritrpticin is remarkable because of its high content of Arg (30%), Trp (23%), and Pro (15%). Trp and Pro residues are known to play important roles in the assembly and structure of membrane proteins (18, 19) .
In this study we investigated the in vitro activities of tritrpticin alone and in combination with six clinically used antimicrobial agents against several multidrugresistant strains of P. aeruginosa isolated from wound infections, bronchoalveolar lavage or blood of hospitalized patients. 
LPS-binding assay.
A quantitative chromogenic Limulus amebocyte assay was performed using the QCL-1000 kit (BioWhittaker, Walkersville, Md., USA) as described previously (9) . The change in optical density (∆OD) was calculated for the control sample, which contained the peptide with no LPS, and this value was subtracted from the ∆OD for samples containing both the peptide and LPS. Percent peptide-LPS binding was calculated from the quotient (Q) of the ∆OD with peptide divided by the ∆OD peptide-free controls, using the formula (1-Q) × 100. Standard curves generated All P. aeruginosa strains organisms were inhibited by tritrpticin at concentrations of 0.5 to 8 mg/l. Differently, high rates of resistance to the clinically used antibiotics were demonstrated. The results are summarized in Table 1 . As shown in the same Table, the good activity of tritrpticin was confirmed by the MBC values (range of 0.5 -32 mg/l) comparable to those of colistin and lower than other antibiotics.
Killing by tritrpticin was shown to be very rapid: its activity against the organism was complete after a 30 min exposure period at a concentration of 2×MIC (Fig. 1) . Colistin showed a killing activity a slightly slower than tritrpticin (60 min). On the contrary, as Table 2 . These data were confirmed by the time kill synergy studies (data not shown).
Our data demonstrate that tritrpticin has a powerful antimicrobial and bactericidal effect on multiresistant clinical isolates of P. aeruginosa. Its activity is comparable to that of colistin and stronger than the other clinically used antibiotics. In addition, it completely inhibits the LPS procoagulant activity at 10 µM concentration although, when compared to colistin on a molar basis, it exhibited an approximately fivefold lower inhibition activity.
Interaction studies suggest that it could be usefully administered in The ranges of concentrations tested were: 0.125-64 mg/l for tritrpticin and 0.25-256 mg/l for the other antimicrobial agents.
A C C E P T E D
The FIC indexes were interpreted as follows: <0.5, synergy; 0.5-4.0, indifferent; and >4.0, antagonism (13) .
a TZP, tazobactam/piperacillin
